Cargando…

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Detalles Bibliográficos
Autores principales:	Pasello, Michela, Giudice, Anna Maria, Cristalli, Camilla, Manara, Maria Cristina, Mancarella, Caterina, Parra, Alessandro, Serra, Massimo, Magagnoli, Giovanna, Cidre-Aranaz, Florencia, Grünewald, Thomas G. P., Bini, Carla, Lollini, Pier-Luigi, Longhi, Alessandra, Donati, Davide Maria, Scotlandi, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747819/ https://www.ncbi.nlm.nih.gov/pubmed/36352194 http://dx.doi.org/10.1007/s13402-022-00735-z

Ejemplares similares

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018)

CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling
por: Manara, Maria Cristina, et al.
Publicado: (2016)

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma
por: Martinelli, Marcella, et al.
Publicado: (2022)

EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2015)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
por: Zucchini, Cinzia, et al.
Publicado: (2019)

CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018)

CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018)

Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021)

Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
por: Ceranski, A. Katharina, et al.
Publicado: (2023)

A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response
por: Pellegrini, Evelin, et al.
Publicado: (2022)

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
por: Mancarella, Caterina, et al.
Publicado: (2020)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
por: Mancarella, Caterina, et al.
Publicado: (2020)

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021)

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents
por: Mancarella, Caterina, et al.
Publicado: (2015)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
por: Pinca, Rosa Simona, et al.
Publicado: (2017)

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
por: Carrabotta, Marianna, et al.
Publicado: (2022)

Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
por: Garofalo, Cecilia, et al.
Publicado: (2013)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
por: Chiarini, Francesca, et al.
Publicado: (2022)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019)

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
por: Mancarella, Caterina, et al.
Publicado: (2023)

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
por: Cristalli, Camilla, et al.
Publicado: (2022)

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients
por: Savola, Suvi, et al.
Publicado: (2011)

Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications
por: Amaral, Ana Teresa, et al.
Publicado: (2014)

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
por: Berthold, Ruth, et al.
Publicado: (2022)

Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
por: Dallmayer, Marlene, et al.
Publicado: (2019)

miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness
por: De Feo, Alessandra, et al.
Publicado: (2022)

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
por: Mancarella, Caterina, et al.
Publicado: (2023)

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
por: Palmerini, Emanuela, et al.
Publicado: (2022)

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
por: Ohmura, Shunya, et al.
Publicado: (2021)

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis
por: Chakraborty, Sukanya, et al.
Publicado: (2023)

Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
por: Knott, Maximilian M. L., et al.
Publicado: (2020)

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1
por: Palmerini, Emanuela, et al.
Publicado: (2017)

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers
por: Mancarella, Caterina, et al.
Publicado: (2022)

Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
por: Deng, Qu, et al.
Publicado: (2022)

Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
por: Marchetto, Aruna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_imrhgo089ljrkvac4ikmhl6mj7